Lv7
4980 积分 2020-12-06 加入
Species Selection for Pharmaceutical Toxicity Studies
8天前
已完结
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
9天前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
9天前
已完结
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
16天前
已完结
Structural and Physicochemical Features of Oral PROTACs
16天前
已完结
IMHB-Mediated Chameleonicity in Drug Design: A Focus on Structurally Related PROTACs
16天前
已完结
Anti-PEG antibodies: Current situation and countermeasures
19天前
已完结
Deciphering the Role of PEGylation on the Lipid Nanoparticle-Mediated mRNA Delivery to the Liver
24天前
已完结
Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate
28天前
已完结
Total Synthesis of Enlicitide Decanoate
1个月前
已完结
皖公网安备34019202002308
